Egle Ramelyte

1.3k total citations
56 papers, 663 citations indexed

About

Egle Ramelyte is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Egle Ramelyte has authored 56 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 24 papers in Molecular Biology and 22 papers in Dermatology. Recurrent topics in Egle Ramelyte's work include CAR-T cell therapy research (14 papers), Cutaneous lymphoproliferative disorders research (12 papers) and Melanoma and MAPK Pathways (11 papers). Egle Ramelyte is often cited by papers focused on CAR-T cell therapy research (14 papers), Cutaneous lymphoproliferative disorders research (12 papers) and Melanoma and MAPK Pathways (11 papers). Egle Ramelyte collaborates with scholars based in Switzerland, United States and Germany. Egle Ramelyte's co-authors include Reinhard Dummer, Simone M. Goldinger, Regina Krattinger, Florentia Dimitriou, Marjam J. Barysch, Sara Micaletto, Emmanuella Guenova, Mitchell P. Levesque, Patrick Turko and Valerie C. Amann and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Egle Ramelyte

53 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Egle Ramelyte Switzerland 13 329 228 194 160 155 56 663
Leah J. Hogdal United States 12 236 0.7× 412 1.8× 101 0.5× 203 1.3× 136 0.9× 20 831
Ulrich M. Caroli Germany 9 304 0.9× 254 1.1× 107 0.6× 212 1.3× 123 0.8× 12 631
William K. Witmer United States 7 339 1.0× 136 0.6× 268 1.4× 187 1.2× 146 0.9× 7 635
Hamid Echchakir France 19 463 1.4× 263 1.2× 250 1.3× 811 5.1× 122 0.8× 29 1.2k
Willem H. Zoutman Netherlands 13 164 0.5× 227 1.0× 329 1.7× 264 1.6× 145 0.9× 27 694
Amy Kramer United States 9 454 1.4× 403 1.8× 67 0.3× 402 2.5× 245 1.6× 11 1.0k
John Copier United Kingdom 15 270 0.8× 379 1.7× 36 0.2× 449 2.8× 129 0.8× 29 902
S.F. Tsai Taiwan 14 131 0.4× 195 0.9× 104 0.5× 178 1.1× 35 0.2× 20 565
Virginia Cecconi Switzerland 12 357 1.1× 310 1.4× 75 0.4× 680 4.3× 51 0.3× 21 964
Stefanie Loeser Austria 7 301 0.9× 341 1.5× 92 0.5× 479 3.0× 45 0.3× 7 813

Countries citing papers authored by Egle Ramelyte

Since Specialization
Citations

This map shows the geographic impact of Egle Ramelyte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egle Ramelyte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egle Ramelyte more than expected).

Fields of papers citing papers by Egle Ramelyte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Egle Ramelyte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egle Ramelyte. The network helps show where Egle Ramelyte may publish in the future.

Co-authorship network of co-authors of Egle Ramelyte

This figure shows the co-authorship network connecting the top 25 collaborators of Egle Ramelyte. A scholar is included among the top collaborators of Egle Ramelyte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Egle Ramelyte. Egle Ramelyte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grün, Jens von der, S. Psoroulas, J. Krayenbuehl, et al.. (2025). First-in-human e-Flash radiotherapy using a modified conventional C-arm linear accelerator. Clinical and Translational Radiation Oncology. 56. 101047–101047.
2.
Dummer, Reinhard, et al.. (2025). Pruritus Is an Indicator for Quality of Life in Cutaneous T‐Cell Lymphoma. The Journal of Dermatology. 52(9). 1404–1410.
3.
Papadopoulos, Kyriakos P., Manish Sharma, Reinhard Dummer, et al.. (2024). Results of a phase 1, dose-finding study of Debio 0123 as monotherapy in adult patients with advanced solid tumors: Safety, pharmacokinetic, and preliminary antitumor activity data.. Journal of Clinical Oncology. 42(16_suppl). 3120–3120. 5 indexed citations
4.
Roccuzzo, Gabriele, Egle Ramelyte, Chiara Astrua, et al.. (2024). Advances in the pharmacological management of cutaneous T-cell lymphoma. Expert Opinion on Pharmacotherapy. 25(7). 885–894. 1 indexed citations
5.
Ramelyte, Egle, Andrea Lawless, Stefan W. Schneider, et al.. (2024). 25P Circulating tumor DNA is predictive of overall survival in patients with metastatic uveal melanoma. Immuno-Oncology Technology. 24. 100907–100907. 1 indexed citations
6.
7.
Bellini, Elisa, Patrick Turko, Phil F. Cheng, et al.. (2022). The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma. Cancers. 14(17). 4158–4158. 10 indexed citations
8.
Pamplona, Gustavo Santo Pedro, Julia‐Tatjana Maul, Reinhard Dummer, et al.. (2022). Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. Cancers. 14(10). 2360–2360. 12 indexed citations
9.
Ramelyte, Egle, Aizhan Tastanova, Zsolt Balázs, et al.. (2021). Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective. Cancer Cell. 39(3). 394–406.e4. 79 indexed citations
10.
Dimitriou, Florentia, Anne Zaremba, Clara Allayous, et al.. (2021). Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response. European Journal of Cancer. 149. 37–48. 17 indexed citations
11.
Ramelyte, Egle, et al.. (2021). 1089TiP Efficacy and tolerability of anti-PD1 antibody in combination with pulsed hedgehog inhibitor in advanced basal cell carcinoma. Annals of Oncology. 32. S901–S901. 4 indexed citations
12.
Greenshields‐Watson, Alexander, L. Vincent Collins, Egle Ramelyte, et al.. (2021). 1772P Demonstration of T cell redirection and immune activation in skin rash following tebentafusp treatment. Annals of Oncology. 32. S1215–S1215. 3 indexed citations
13.
Dummer, Reinhard, Maarten H. Vermeer, Julia Scarisbrick, et al.. (2021). Cutaneous T cell lymphoma. Nature Reviews Disease Primers. 7(1). 61–61. 83 indexed citations
14.
Tastanova, Aizhan, Egle Ramelyte, Zsolt Balázs, et al.. (2021). Collection and preprocessing of fine needle aspirate patient samples for single cell profiling and data analysis. STAR Protocols. 2(2). 100581–100581. 2 indexed citations
15.
Ramelyte, Egle, Gaetana Restivo, Laurence Imhof, Mirjam Nägeli, & Reinhard Dummer. (2020). How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma?. British Journal of Dermatology. 184(2). 359–361. 10 indexed citations
16.
Ramelyte, Egle, et al.. (2019). Radiotherapy in Periocular Cutaneous Malignancies: A Retrospective Study. Dermatology. 235(3). 234–239. 9 indexed citations
17.
Dimitriou, Florentia, Regina Krattinger, Egle Ramelyte, et al.. (2018). The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe. Current Oncology Reports. 20(11). 87–87. 126 indexed citations
18.
Ramelyte, Egle, Matilda Bylaitė-Bučinskienė, Reinhard Dummer, & Laurence Imhof. (2017). Successful Use of Grenz Rays for Disseminated Superficial Actinic Porokeratosis: Report of 8 Cases. Dermatology. 233(2-3). 217–222. 8 indexed citations
19.
Ramelyte, Egle, Valerie C. Amann, & Reinhard Dummer. (2016). Sonidegib for the treatment of advanced basal cell carcinoma. Expert Opinion on Pharmacotherapy. 17(14). 1963–1968. 12 indexed citations
20.
Amann, Valerie C., et al.. (2016). Developments in targeted therapy in melanoma. European Journal of Surgical Oncology. 43(3). 581–593. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leah J. Hogdal Breakdown of academic impact, for papers by Ulrich M. Caroli Breakdown of academic impact, for papers by William K. Witmer Breakdown of academic impact, for papers by Hamid Echchakir Breakdown of academic impact, for papers by Willem H. Zoutman Breakdown of academic impact, for papers by Amy Kramer Breakdown of academic impact, for papers by John Copier Breakdown of academic impact, for papers by S.F. Tsai Breakdown of academic impact, for papers by Virginia Cecconi Breakdown of academic impact, for papers by Stefanie Loeser
Rankless by CCL
2026